On Tuesday, Apogee Therapeutics Inc (NASDAQ: APGE) opened lower -12.35% from the last session, before settling in for the closing price of $39.35. Price fluctuations for APGE have ranged from $33.14 to $72.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 7.88% at the time writing. With a float of $36.30 million, this company’s outstanding shares have now reached $45.02 million.
In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Apogee Therapeutics Inc (APGE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Apogee Therapeutics Inc is 37.96%, while institutional ownership is 80.58%. The most recent insider transaction that took place on Feb 05 ’25, was worth 143,229. In this transaction Chief Medical Officer of this company sold 3,520 shares at a rate of $40.69, taking the stock ownership to the 252,623 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Chief Executive Officer sold 15,000 for $40.58, making the entire transaction worth $608,700. This insider now owns 1,302,987 shares in total.
Apogee Therapeutics Inc (APGE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.88% per share during the next fiscal year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Check out the current performance indicators for Apogee Therapeutics Inc (APGE). In the past quarter, the stock posted a quick ratio of 16.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.73, a number that is poised to hit -1.08 in the next quarter and is forecasted to reach -4.32 in one year’s time.
Technical Analysis of Apogee Therapeutics Inc (APGE)
Analysing the last 5-days average volume posted by the [Apogee Therapeutics Inc, APGE], we can find that recorded value of 0.59 million was better than the volume posted last year of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 6.59%. Additionally, its Average True Range was 2.63.
During the past 100 days, Apogee Therapeutics Inc’s (APGE) raw stochastic average was set at 0.92%, which indicates a significant decrease from 2.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.97% in the past 14 days, which was lower than the 69.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.94, while its 200-day Moving Average is $47.67. Now, the first resistance to watch is $37.72. This is followed by the second major resistance level at $40.94. The third major resistance level sits at $42.69. If the price goes on to break the first support level at $32.74, it is likely to go to the next support level at $30.99. Should the price break the second support level, the third support level stands at $27.77.
Apogee Therapeutics Inc (NASDAQ: APGE) Key Stats
There are currently 45,027K shares outstanding in the company with a market cap of 2.02 billion. Presently, the company’s annual sales total 0 K according to its annual income of -83,990 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -49,020 K.
